Opinion of the Italian Association of Myology on Ataluren for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy.
- Published in:
- Drugs in R&D, 2025, v. 25, n. 2, p. 99, doi. 10.1007/s40268-025-00512-x
- By:
- Publication type:
- Article
Works matching IS 11745886 AND DT 2025 AND VI 25 AND IP 2
Results: 7
1
2
Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema.
- Published in:
- Drugs in R&D, 2025, v. 25, n. 2, p. 161, doi. 10.1007/s40268-025-00511-y
- By:
- Publication type:
- Article
3
Evaluation of Anti-SARS-CoV-2 IgG Responses in a Clinical Study of a Biosimilar Candidate to Denosumab Using Singlicate Analysis.
- Published in:
- Drugs in R&D, 2025, v. 25, n. 2, p. 141, doi. 10.1007/s40268-025-00510-z
- By:
- Publication type:
- Article
4
Bioequivalence and Safety of Two Amisulpride Formulations in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study.
- Published in:
- Drugs in R&D, 2025, v. 25, n. 2, p. 117, doi. 10.1007/s40268-025-00508-7
- By:
- Publication type:
- Article
5
Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA).
- Published in:
- Drugs in R&D, 2025, v. 25, n. 2, p. 107, doi. 10.1007/s40268-025-00507-8
- By:
- Publication type:
- Article
6
Safety Evaluation of Contezolid (MRX-I) Versus Linezolid in Sprague-Dawley Rats.
- Published in:
- Drugs in R&D, 2025, v. 25, n. 2, p. 127, doi. 10.1007/s40268-025-00504-x
- By:
- Publication type:
- Article
7
An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate.
- Published in:
- Drugs in R&D, 2025, v. 25, n. 2, p. 153, doi. 10.1007/s40268-025-00509-6
- By:
- Publication type:
- Article